PicnicHealth raises $60 million

PicnicHealth , a patient-centered health technology company, has closed a $60 million Series C financing round led by new investor B Capital Group. Existing investors Felicis Ventures and Amplify Partners also joined the round, bringing the total PicnicHealth has raised to more than $100 million. The company also announced plans to build 30 new patient-centered real-world data cohorts, and the addition of Adam Seabrook, Partner at B Capital Group, to the PicnicHealth board of directors.

Founded in 2014, the company uses machine learning to build datasets for life sciences by working directly with patients and giving them single-source access to their data. All datasets include complete medical records from all of a patient’s sites of care and can be supplemented with direct patient-reported experience and linked to other research data sources.

So far, it has helped create patient-centered real-world data cohorts in hematology (including hemophilia, sickle cell disease, paroxysmal nocturnal hemoglobinuria, and immune thrombocytopenia); neurology (including multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, myasthenia gravis, and Huntington’s disease); and rare diseases (including lupus nephritis, primary biliary cholangitis, and Pompe disease).